Group 2 innate lymphoid cells (ILC2s; also called nuocytes, innate helper cells, or natural helper cells) provide protective immunity during helminth infection and play an important role in influenza-induced and allergic airway hyperreactivity. Whereas the transcription factor GATA binding protein 3 (
Gata3
) is important for the production of IL-5 and -13 by ILC2s in response to IL-33 or -25 stimulation, it is not known whether
Gata3
is required for ILC2 development from hematopoietic stem cells. Here, we show that chimeric mice generated with
Gata3
-deficient fetal liver hematopoietic stem cells fail to develop systemically dispersed ILC2s. In these chimeric mice, in vivo administration of IL-33 or -25 fails to expand ILC2 numbers or to induce characteristic ILC2-dependent IL-5 or -13 production. Moreover, cell-intrinsic
Gata3
expression is required for ILC2 development in vitro and in vivo. Using mutant and transgenic mice in which
Gata3
gene copy number is altered, we show that ILC2 generation from common lymphoid progenitors, as well as ILC2 homeostasis and cytokine production, is regulated by
Gata3
expression levels in a dose-dependent fashion. Collectively, these results identify
Gata3
as a critical early regulator of ILC2 development, thereby extending the paradigm of
Gata3
-dependent control of type 2 immunity to include both innate and adaptive lymphocytes.